Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce that the latest annual report ...

For patients with obesity undergoing joint replacement, higher weight loss after initiating antiobesity medications within 1 year is associated with a lower risk for revision.

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce that the latest annual report from the Australian Orthopaedic Association National Joint Replacement ...

South Peninsula Hospital now offers total hip replacement surgeries locally through South Peninsula Orthopedics.

Medical Center earned The Joint Commission's Gold Seal of Approval for Joint Replacement for hip and knee replacements, accord ...

Hip Innovation Technology, LLC (HIT), a medical device company developing innovative orthopedic device solutions to advance the quality of life and quality of care for patients, is announcing the Food ...

ChristianaCare surgeons have performed the first robotic joint replacement procedures in Northern Delaware using Mako robotic ...

Good news for people with joint pain! A recent study suggests that a pill called colchicine could lower the chances of ...

While 84% of patients get excellent results with arthroscopy, 22% to 30% of those over 40 may ultimately need a hip replacement. The labrum is a rim of cartilage surrounding the hip joint and holding ...

Obesity is a major risk factor for joint failure because excess weight puts more stress on the implants, leading to ...

Higher weight loss after initiating antiobesity meds linked to lower risk for revision of hip and knee replacement. HealthDay News — For patients with obesity undergoing joint replacement ...

A study finds that weight loss after joint replacement surgery, aided by anti-obesity medications, reduces the risk of ...